Finance

Lists
Why is HIMS down ၈.၈၆%?
Dive Deeper
HIMS:NYSE
Hims & Hers Health Inc
၁၄.၆၀ US$
-၈.၈၆%
(-၁.၄၂) 1D
၁၅.၁၃ US$
+၃.၆၃% (+၀.၅၃)
After hours
Closed: နို ၂၀, GMT-၅ ၁၆:၀၀:၀၃  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HIMS...
Open
၁၅.၅၁ US$
High
၁၅.၉၆ US$
Low
၁၄.၅၁ US$
Mkt. cap
၃၄၂.၂၄ ဋေ
Avg. vol.
၁.၄၂ ကုဋေ
Volume
၁.၆၁ ကုဋေ
52-wk high
၄၀.၉၉ US$
52-wk low
၁၃.၇၄ US$
EPS
-၀.၈၃ US$
Beta
၂.၅၃
Shares outstanding
၂၂.၆၀ ကုဋေ
No. of employees
၂ ထောင်
Open
၁၅.၅၁ US$
High
၁၅.၉၆ US$
Low
၁၄.၅၁ US$
Mkt. cap
၃၄၂.၂၄ ဋေ
Avg. vol.
၁.၄၂ ကုဋေ
Volume
၁.၆၁ ကုဋေ
52-wk high
၄၀.၉၉ US$
52-wk low
၁၃.၇၄ US$
EPS
-၀.၈၃ US$
Beta
၂.၅၃
Shares outstanding
၂၂.၆၀ ကုဋေ
No. of employees
၂ ထောင်
News stories
From web sources and news partners
News Corp
News Corp
·
ပြီးခဲ့သည့် ၁၇ နာရီ
Investors fled to healthcare stocks for safety. Now insurance and hospital shares are plunging.
Zacks
Zacks
·
ပြီးခဲ့သည့် ၁၈ နာရီ
Hims & Hers Launches Peptides+ to Expand Personalized Health Care
www.tokenpost.com
www.tokenpost.com
·
ပြီးခဲ့သည့် ၂၀ နာရီ
Hims & Hers Health Shares Drop 10.64% to $15.54 in Nov. 20 Snapshot
Investing.com
Investing.com
·
ပြီးခဲ့သည့် ၂၂ နာရီ
BofA cuts Hims and Hers stock price target on Kentucky peptide ban
Profile
Hims & Hers Health, Inc., doing business as hims, is an American telehealth company headquartered in San Francisco. It provides prescription medications, over-the-counter medications, and personal care products through a direct-to-consumer subscription model. Wikipedia
About Hims & Hers Health Inc
CEO-
Employees၂.၄၄ ထောင်
Foundedနို ၂၀၁၇
Headquartersဆန်ဖရန်စစ္စကိုမြို့, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
SectorHealth Care
IndustryHealth care provider
Website-
Analyst ratings
Based on 12 analysts giving stock ratings to HIMS in the past 3 months
Hold
Buy
3
Hold
9
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for HIMS in the last 3 months.
Highest
Current ၁၄.၆၀ US$
၄၀.၀၀ US$ (+၁၇၃.၉၇%)
Average
၂၈.၄၀ US$ (+၉၄.၅၂%)
Lowest
၂၁.၀၀ US$ (+၄၃.၈၄%)
Analyst
Recommendation
Action
Price target
Projected
Date
Allen Lutz
Bank of America Securities
Hold
Reiterated
၂၁.၀၀ US$
+၄၃.၈%
11/19/2026
Justin Patterson
KeyBanc
Hold
Maintained
-
-
11/11/2026
Michael Cherny
Leerink Partners
Hold
Maintained
၂၄.၀၀ US$
+၆၄.၄%
11/10/2026
Bryan Smilek
J.P. Morgan
Hold
Maintained
၂၄.၀၀ US$
+၆၄.၄%
11/10/2026
Mark Mahaney
Evercore ISI
Hold
Maintained
၂၇.၀၀ US$
+၈၄.၉%
11/10/2026
Brian Tanquilut
Jefferies
Hold
Maintained
၂၄.၀၀ US$
+၆၄.၄%
11/10/2026
Craig Hettenbach
Morgan Stanley
Hold
Reiterated
၂၅.၀၀ US$
+၇၁.၂%
11/10/2026
Ryan MacDonald
Needham
Buy
Reiterated
၃၂.၀၀ US$
+၁၁၉.၂%
11/10/2026
Maria Ripps
Canaccord Genuity
Buy
Maintained
၄၀.၀၀ US$
+၁၇၄%
11/10/2026
David Larsen
BTIG
Hold
Maintained
-
-
11/09/2026
Glen Santangelo
Barclays
Buy
Maintained
၃၅.၀၀ US$
+၁၃၉.၇%
11/10/2026
Jailendra Singh
Truist Financial
Hold
Reiterated
၃၂.၀၀ US$
+၁၁၉.၂%
09/11/2026
George Hill
Deutsche Bank
Hold
Reiterated
၂၆.၀၀ US$
+၇၈.၁%
08/11/2026
Jonna Kim
TD Cowen
Hold
Reiterated
၃၀.၀၀ US$
+၁၀၅.၅%
08/11/2026
Daniel Grosslight
Citi
Hold
Maintained
၃၃.၀၀ US$
+၁၂၆%
08/12/2026
Oliver Chen
TD Cowen
Hold
Reiterated
၂၅.၀၀ US$
+၇၁.၂%
05/12/2026
Cory Carpenter
J.P. Morgan
Buy
Maintained
၃၃.၀၀ US$
+၁၂၆%
05/12/2026
Unknown Analyst
Nephron
Buy
Upgraded
၃၅.၀၀ US$
+၁၃၉.၇%
03/09/2026
Last report
၂၀၂၆ နို ၁၀
Fiscal period
Q3 2026
၀.၀၃ US$ / ၀.၁၅ US$
-၈၁.၉၇%miss
Revenue / Est. (USD)
၈၉.၀၄ ကုဋေ / ၈၉.၂၈ ကုဋေ
-၀.၂၇%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
၂၀၂၆ စက်
Revenue
၆၁.၇၈ ကုဋေ
၆၀.၈၁ ကုဋေ
၇၅.၃၂ ကုဋေ
၈၉.၀၄ ကုဋေ
Cost of goods sold
၁၇.၃၄ ကုဋေ
၁၈.၂၈ ကုဋေ
၂၇.၂၄ ကုဋေ
၃၈.၁၂ ကုဋေ
Cost of revenue
၁၇.၃၄ ကုဋေ
၁၈.၂၈ ကုဋေ
၂၇.၂၄ ကုဋေ
၃၈.၁၂ ကုဋေ
Research and development expenses
၄.၁၀ ကုဋေ
၄.၆၉ ကုဋေ
၅.၄၉ ကုဋေ
၆.၉၄ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၃၈.၆၆ ကုဋေ
၄၂.၆၄ ကုဋေ
၅၂.၁၉ ကုဋေ
၅၀.၆၀ ကုဋေ
Operating expense
၄၂.၇၆ ကုဋေ
၄၇.၃၃ ကုဋေ
၅၇.၆၈ ကုဋေ
၅၇.၅၃ ကုဋေ
Total operating expenses
၆၀.၁၀ ကုဋေ
၆၅.၆၁ ကုဋေ
၈၄.၉၃ ကုဋေ
၉၅.၆၅ ကုဋေ
Operating income
၁.၆၈ ကုဋေ
-၄.၈၀ ကုဋေ
-၉.၆၀ ကုဋေ
-၆.၆၁ ကုဋေ
Other non operating income
၁.၈၂ သန်း
-၁.၈၆ ကုဋေ
-၂.၄၃ သန်း
-၅.၁၄ သိန်း
EBT including unusual items
၁.၈၄ ကုဋေ
-၁၀.၁၆ ကုဋေ
-၉.၂၆ ကုဋေ
-၄.၆၂ ကုဋေ
EBT excluding unusual items
၂.၁၆ ကုဋေ
-၆.၁၆ ကုဋေ
-၉.၆၂ ကုဋေ
-၆.၇၄ ကုဋေ
Income tax expense
-၂.၂၅ သန်း
-၉.၄၄ သန်း
-၆.၃၄ သန်း
-၁.၃၂ ကုဋေ
Effective tax rate
-၁၂.၂၅%
၉.၂၉%
၆.၈၅%
၂၈.၅၆%
Other operating expenses
-
-
-
-
Net income
၂.၀၆ ကုဋေ
-၉.၂၁ ကုဋေ
-၈.၆၃ ကုဋေ
-၃.၃၀ ကုဋေ
Net profit margin
၃.၃၃%
-၁၅.၁၅%
-၁၁.၄၆%
-၃.၇၁%
Earnings per share
၀.၂၂
-၀.၁၉
-၀.၀၉
၀.၀၃
Interest and investment income
၃.၈၃ သန်း
၇.၉၀ သန်း
၆.၀၀ သန်း
၄.၈၀ သန်း
Interest expense
-၉.၂၁ သိန်း
-၂.၈၇ သန်း
-၃.၇၅ သန်း
-၅.၅၀ သန်း
Net interest expenses
၂.၉၀ သန်း
၅.၀၃ သန်း
၂.၂၅ သန်း
-၇.၀၂ သိန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
၃.၄၉ ကုဋေ
-၂.၆၁ ကုဋေ
-၆.၆၆ ကုဋေ
-၂.၇၉ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google အက်ပ်များ